Fachbereich Biowissenschaften, Merck Stiftungsprofessur für Molekulare Biotechnologie, Goethe-Universität Frankfurt, Frankfurt am Main, Germany.
Buchmann Institute for Molecular Life Sciences (BMLS), Goethe-Universität Frankfurt, Frankfurt am Main, Germany.
PLoS One. 2018 Mar 29;13(3):e0194297. doi: 10.1371/journal.pone.0194297. eCollection 2018.
The pyrrolobenzodiazepine tilivalline (1) was originally identified in the human gut pathobiont Klebsiella oxytoca, the causative agent of antibiotic-associated hemorrhagic colitis. Here we show the identification of tilivalline and analogs thereof in the entomopathogenic bacterium Xenorhabdus eapokensis as well as the identification of its biosynthesis gene cluster encoding a bimodular non-ribosomal peptide synthetase. Heterologous expression of both genes in E. coli resulted in the production of 1 and from mutasynthesis and precursor directed biosynthesis 11 new tilivalline analogs were identified in X. eapokensis. These results allowed the prediction of the tilivalline biosynthesis being similar to that in K. oxytoca.
吡咯并苯并二氮杂卓替利瓦定(1)最初在人类肠道共生菌产酸克雷伯氏菌(Klebsiella oxytoca)中被鉴定出来,产酸克雷伯氏菌是抗生素相关性出血性结肠炎的病原体。在这里,我们在昆虫病原细菌费氏弧菌(Xenorhabdus eapokensis)中也鉴定出了替利瓦定及其类似物,同时鉴定出了编码双模块非核糖体肽合成酶的生物合成基因簇。将这两个基因在大肠杆菌中的异源表达导致了 1 的产生,并且通过突变合成和前体定向生物合成,在费氏弧菌中鉴定出了 11 种新的替利瓦定类似物。这些结果表明,替利瓦定的生物合成与产酸克雷伯氏菌中的生物合成相似。